<scp>FLIP</scp> as a therapeutic target in cancerLuke Humphreys, Daniel B. Longley, Margarita Espona‐Fiedler|FEBS Journal|2018Cited by 86
The SCFSkp2 ubiquitin ligase complex modulates TRAIL-R2-induced apoptosis by regulating FLIP(L)Jamie Z. Roberts, Daniel B. Longley, Tamas Sessler et al.|Cell Death and Differentiation|2020Cited by 40
Development and pre-clinical assessment of a first-in-class small molecule inhibitor of FLIP for treatment of NSCLC and CRCCatherine Higgins, Daniel B. Longley, Joanna Majkut et al.|European Journal of Cancer|2016Cited by 2